Abstract
Jiangsu Chia-Tai Tianqing Pharmaceutical and Advenchen Laboratories are co-developing anlotinib (Focus V (R)) for the treatment of advanced cancer. An......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
